Non-alcoholic fatty liver disease: the pathologist’s perspective
Clinical and Molecular Hepatology · 28.02.2023 · 29 (Suppl) · S302-S318
DOI: 10.3350/cmh.2022.0329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 28.02.2023. Verfasst von Wei-Qiang Leow und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of diseases characterized by fatty accumulation in hepatocytes, ranging from steatosis, non-alcoholic steatohepatitis, to cirrhosis. While histopathological evaluation of liver biopsies plays a central role in the diagnosis of NAFLD, limitations such as the problem of interobserver variability still exist and active research is underway to improve the diagnostic utility of liver biopsies. In this article, we provide a comprehensive overview of the histopathological features of NAFLD, the current grading and staging systems, and discuss the present and future roles of liver biopsies in the diagnosis and prognostication of NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
- Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
- Pathology and Laboratory Department, Cardinal Santos Medical Center, San Juan, Philippines.
- Department of Pathology and State Key Laboratory of Liver Research (HKU), The University of Hong Kong, Hong Kong, China.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Leow, W. Q., Chan, A. W., Mendoza, P. G. L., Lo, R., Yap, K., & Kim, H. (2023). Non-alcoholic fatty liver disease: the pathologist’s perspective. Clinical and Molecular Hepatology, 29(Suppl), S302-S318. https://doi.org/10.3350/cmh.2022.0329
Vancouver
Leow WQ, Chan AW, Mendoza PGL, Lo R, Yap K, Kim H. Non-alcoholic fatty liver disease: the pathologist’s perspective. Clinical and Molecular Hepatology. 2023;29(Suppl):S302-S318. doi:10.3350/cmh.2022.0329
BibTeX
@article{Leow2023,
author = {Leow, Wei-Qiang and Chan, Anthony Wing-Hung and Mendoza, Paulo Giovanni L and Lo, Regina and Yap, Kihan and Kim, Haeryoung},
title = {Non-alcoholic fatty liver disease: the pathologist’s perspective},
journal = {Clinical and Molecular Hepatology},
year = {2023},
volume = {29},
number = {Suppl},
pages = {S302--S318},
doi = {10.3350/cmh.2022.0329}
}
EUVIMED